TAG: public health access

Ozempic patent expiry promises major shift in public health access and cost savings by 2025

23/03/2026

Brazilian semaglutide patent expiration in 2025 to boost generic access amid legal precedents

13/03/2026

Finerenone barred from SUS, limiting critical kidney protection for type 2 diabetes patients

19/02/2026